NYSE:ARE - US0152711091 - REIT
The current stock price of ARE is 80.93 USD. In the past month the price decreased by -1.53%. In the past year, price decreased by -33.23%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL | WELLTOWER INC | 92.9 | 109.98B | ||
VTR | VENTAS INC | 157.65 | 30.60B | ||
DOC | HEALTHPEAK PROPERTIES INC | 73.96 | 12.33B | ||
OHI | OMEGA HEALTHCARE INVESTORS | 25.01 | 12.23B | ||
CTRE | CARETRUST REIT INC | 28 | 7.69B | ||
AHR | AMERICAN HEALTHCARE REIT INC | N/A | 6.77B | ||
HR | HEALTHCARE REALTY TRUST INC | N/A | 5.97B | ||
SBRA | SABRA HEALTH CARE REIT INC | 25.72 | 4.65B | ||
DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 4.27B | ||
DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 4.13B | ||
NHI | NATL HEALTH INVESTORS INC | 26.04 | 3.64B | ||
MPW | MEDICAL PROPERTIES TRUST INC | N/A | 2.59B |
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 552 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.
ALEXANDRIA REAL ESTATE EQUIT
26 North Euclid Avenue
Pasadena CALIFORNIA 91101 US
CEO: Stephen A. Richardson
Employees: 552
Phone: 16265780777
The current stock price of ARE is 80.93 USD. The price increased by 4.55% in the last trading session.
The exchange symbol of ALEXANDRIA REAL ESTATE EQUIT is ARE and it is listed on the New York Stock Exchange, Inc. exchange.
ARE stock is listed on the New York Stock Exchange, Inc. exchange.
17 analysts have analysed ARE and the average price target is 101.17 USD. This implies a price increase of 25% is expected in the next year compared to the current price of 80.93. Check the ALEXANDRIA REAL ESTATE EQUIT stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ALEXANDRIA REAL ESTATE EQUIT (ARE) has a market capitalization of 14.00B USD. This makes ARE a Large Cap stock.
ALEXANDRIA REAL ESTATE EQUIT (ARE) currently has 552 employees.
ALEXANDRIA REAL ESTATE EQUIT (ARE) has a support level at 77.45 and a resistance level at 81.44. Check the full technical report for a detailed analysis of ARE support and resistance levels.
The Revenue of ALEXANDRIA REAL ESTATE EQUIT (ARE) is expected to decline by -2.91% in the next year. Check the estimates tab for more information on the ARE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALEXANDRIA REAL ESTATE EQUIT (ARE) has a dividend yield of 7.09%. The yearly dividend amount is currently 5.22. Check the full fundamental report for a detailed analysis of ARE dividend history, reliability and sustainability.
ALEXANDRIA REAL ESTATE EQUIT (ARE) will report earnings on 2025-10-20, after the market close.
ALEXANDRIA REAL ESTATE EQUIT (ARE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.13).
The outstanding short interest for ALEXANDRIA REAL ESTATE EQUIT (ARE) is 3.86% of its float. Check the ownership tab for more information on the ARE short interest.
ChartMill assigns a technical rating of 3 / 10 to ARE. When comparing the yearly performance of all stocks, ARE is a bad performer in the overall market: 81.97% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to ARE. There are concerns on the financial health of ARE while its profitability can be described as average.
Over the last trailing twelve months ARE reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS decreased by -116.05% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.06% | ||
ROE | -0.12% | ||
Debt/Equity | 0.77 |
17 analysts have analysed ARE and the average price target is 101.17 USD. This implies a price increase of 25% is expected in the next year compared to the current price of 80.93.
For the next year, analysts expect an EPS growth of 11.1% and a revenue growth -2.91% for ARE